Novartis Advances its Capabilities in Personalised Medicine with Genoptix Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 2 (Table of Contents)
Published: 7 Feb-2011
DOI: 10.3833/pdr.v2011.i2.1429 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Novartis is to acquire the US cancer diagnostics services company Genoptix in an all-cash deal that is worth US$470 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS